Stryker
Worldwide Headquarters
2825 Airview Boulevard
Kalamazoo
Michigan
49002
United States
Tel: 269-385-2600
Fax: 269-385-1062
Website: http://www.stryker.com/
320 articles about Stryker
-
Stryker reports second quarter 2023 operating results
8/3/2023
Stryker reported operating results for the second quarter of 2023.
-
Stryker declares a $0.75 per share quarterly dividend
8/2/2023
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable October 31, 2023 to shareholders of record at the close of business on September 29, 2023, representing an increase of 7.9% versus the prior year and unchanged from the previous quarter.
-
Stryker Announces Commercial Launch of Q Guidance System With Cranial Guidance Software
7/11/2023
Stryker’s navigation system offers surgeons a comprehensive planning and guidance solution for complex cranial procedures.
-
Stryker launches industry's only fully autonomous guidance system
7/6/2023
Stryker announced the launch of its Ortho Q Guidance system, the only fully autonomous system in the industry, easily controlled by the surgeon from the sterile field.
-
Stryker to announce financial results for its second quarter of fiscal year 2023
6/30/2023
Stryker announced that it will report financial results for second quarter of fiscal year 2023 on Thursday, August 3, 2023.
-
Surgeons Successfully Complete First Surgical Cases Using Stryker’s Q Guidance System with Cranial Guidance Software
5/24/2023
Stryker, one of the world’s leading medical technology companies, announced that Early Product Surveillance cases utilizing its Q Guidance System with Cranial Guidance Software are underway.
-
Stryker declares a $0.75 per share quarterly dividend - May 10, 2023
5/10/2023
Stryker announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable July 31, 2023 to shareholders of record at the close of business on June 30, 2023, representing an increase of 7.9% versus the prior year and unchanged from the previous quarter.
-
Stryker completes acquisition of Cerus Endovascular
5/2/2023
Stryker (NYSE:SYK), one of the world's leading medical technology companies, announced today that it has completed the acquisition of Cerus Endovascular Ltd., a privately held, commercial-stage, medical device company engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms.
-
Stryker reports first quarter 2023 operating results
5/1/2023
Stryker reported operating results for the first quarter of 2023.
-
Stryker Now Offers the Only FDA-Cleared Pyrocarbon Bearing Material Option for Shoulder Hemiarthroplasty
3/30/2023
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, today announced that Armodios M. Hatzidakis, MD, FAAOS, Western Orthopaedics, PC, Denver Surgery Center and Rose Medical Center, has successfully completed the first case in the United States, since the De Novo clearance, using the Tornier Pyrocarbon Humeral Head.
-
Stryker to announce financial results for its first quarter of fiscal year 2023
3/30/2023
Stryker announced that it will report financial results for first quarter of fiscal year 2023 on Monday, May 1, 2023.
-
CD NXT power tool system empowers surgeons through real-time depth measurement
3/2/2023
Stryker announced the launch of its CD NXT System, the latest innovation in the company's power tools.
-
Stryker’s Q Guidance System for cranial applications receives FDA clearance
2/17/2023
Stryker, one of the world’s leading medical technology companies, announced that its Q Guidance System with Cranial Guidance Software received 510 clearance from the U.S. Food and Drug Administration.
-
Stryker reports 2022 operating results and 2023 outlook
1/31/2023
Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2022.
-
Stryker to host conference call on January 31, 2023
12/28/2022
Stryker announced that it will host a conference call on Tuesday, January 31, 2023 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending December 31, 2022 and provide an operational update.
-
Stryker launches Citrefix™ Suture Anchor System, featuring award-winning Citregen biomaterial designed to support bone regeneration and the natural healing process
12/13/2022
Stryker (NYSE:SYK) today announced the launch of Citrefix™, a suture anchor system for foot and ankle surgical procedures.
-
Stryker declares a $0.75 per share quarterly dividend
12/7/2022
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable January 31, 2023 to shareholders of record at the close of business on December 30, 2022, representing an increase of 7.9% versus the prior year and previous quarter.
-
Stryker opens the OR of the Future for customers to experience tomorrow's OR today
11/14/2022
Stryker, one of the world's leading medical technology companies, unveiled the OR of the Future—a model operating room inside Stryker's Flower Mound facility, providing a one-of-a-kind interactive experience for customers to conceptualize new OR design and technology.
-
Stryker to participate in the 5th Annual Evercore ISI HealthCONx Conference
11/3/2022
Stryker will participate in the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022.
-
Stryker reports third quarter 2022 operating results
10/31/2022
Stryker (NYSE:SYK) reported operating results for the third quarter of 2022.